Neurosity

Brooklyn, NYFounded 20181–10 employeesneurosity.co

Neurosity develops consumer-focused technology designed to help people unlock their potential and improve concentration. Its flagship product, The Crown, guides users into a focused state and helps them sustain it, with the company combining hardware and software expertise around brain-powered applications.

Visit neurosity.co ↗

Founded: 2018
Employees: 1–10

reccy insights

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

Recent highlights

Neurosity’s latest clearly documented activity centers on consumer neurotechnology and brain-computer interfaces. On Jun 28, 2023, Bloomberg highlighted the company’s futuristic headband and its focus-enhancement use case. On Dec 17, 2023, TechHQ covered BrainGPT, describing a direction in which brain signals could support thought-to-text applications. The company’s technology portfolio also includes a granted patent dated Jun 30, 2021 for “Headware for computer control,” indicating work beyond wellness tracking toward direct computer interaction. Neurosity raised $4,981,188 in a venture round announced on Oct 7, 2022, with Boost VC and Founders, Inc. identified as investors; the same date also includes a debt-financing entry with no disclosed amount. The company continues to signal interest in expanding its technical capabilities, with hiring emphasis on engineers and neuroscientists. Publicly documented milestones are concentrated in 2021–2023, so there is limited information available on product releases, partnerships, awards, or executive changes after that period.

Market position

Neurosity operates at the intersection of consumer wearables, neurotechnology, productivity software, and developer tooling. Its differentiation is the combination of an EEG headset, software experiences intended to help users enter and sustain focus, and tools that expose device data to developers. That places it near consumer neurofeedback products such as Muse and broader brain-computer-interface platforms such as Emotiv, while its stated focus on programmers gives it a narrower productivity-oriented positioning. Neurosity’s Crown device and related software are aimed at translating brain activity into practical feedback rather than presenting the product solely as a clinical instrument. The company also offers SDKs, APIs, device emulators, and a browser-based console, which can lower the barrier for experimentation and application development. Its $4.98 million disclosed funding total and estimated team size of one to ten employees indicate an early-stage scale relative to better-capitalized hardware and digital-health competitors. The main strategic challenge is converting an attention-grabbing neurotechnology proposition into repeatable consumer engagement, measurable productivity outcomes, and a durable software ecosystem.

Growth & opportunities

Neurosity was founded in 2018 and progressed from three seed financings announced between 2018 and 2020 to a $4,981,188 venture round on Oct 7, 2022, alongside an undisclosed debt-financing entry. Hatcher+ led the 2018 seed round, while later disclosed investors included Myelin VC, Social Starts, Quake Capital Partners, Jon Oringer, Joyance Partners, Boost VC, and Founders, Inc. The company’s product direction appears to have broadened over time: the original Notion positioning emphasized focus and concentration for programmers, while the current portfolio includes the Crown EEG Device, a membership service, developer SDKs and APIs, device emulators, and a browser-based demo console. A 2021 patent for headware-based computer control marks an important technical inflection point, and 2023 coverage of the Crown and BrainGPT indicates continued interest in both focus enhancement and thought-to-text applications. Hiring interest in engineers and neuroscientists suggests ongoing technical development, but the small reported employee band and lack of disclosed funding after 2022 imply a measured rather than aggressively scaled trajectory.

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

What makes Neurosity distinct

reccy insights

What makes Neurosity distinct

01The Crown is designed to help users enter and maintain a focused state.
02Neurosity combines hardware engineering, software development, and neuroscience-focused product thinking.
03The company applies brain-related technology to consumer applications and productivity.
04Its founding team brings experience in robotics automation and large-scale consumer software deployment.
05Neurosity is building a multidisciplinary team spanning engineering and neuroscience.

Technology & products5

Technology & products

Crown EEG Device
A wearable EEG headset that measures brain activity to track focus, calm, and cognitive states for users.
Neurosity Membership
A subscription service providing software features, personalized insights, device repairs, and priority support for Crown users.
Device Emulators
Virtual EEG devices that simulate the Neurosity operating system and hardware features for app development and testing.
Neurosity SDKs and APIs
Software development kits and APIs enabling access to raw EEG data and device metrics for building neurotechnology applications.
Neurosity Demo and Console
A browser-based simulator providing access to the Crown device interface and SDKs for exploration and development without hardware.

Show all 5 products

+ 2 more: Neurosity SDKs and APIs, Neurosity Demo and Console

About Neurosity

Products: Crown EEG Device, Neurosity Membership, Device Emulators, Neurosity SDKs and APIs, Neurosity Demo and Console
Leadership: AJ Keller, CEO
Focus areas: Neurotechnology, wearables, consumer electronics, wellness, AI/ML, digital health, hardware
Headquarters: Brooklyn, NY
Founded: 2018
Employees: 1–10
Patents granted: 1 (Crunchbase)